Page last updated: 2024-09-04

levofloxacin and oxytetracycline, anhydrous

levofloxacin has been researched along with oxytetracycline, anhydrous in 8 studies

Compound Research Comparison

Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010)
(levofloxacin)
Studies
(oxytetracycline, anhydrous)
Trials
(oxytetracycline, anhydrous)
Recent Studies (post-2010) (oxytetracycline, anhydrous)
4,3465812,2096,721267976

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)oxytetracycline, anhydrous (IC50)
microphthalmia-associated transcription factor isoform 9Homo sapiens (human)1.7087

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Feng, L; Li, Y; Lu, T; Qian, H; Zhang, J; Zhang, Z; Zhou, Z1
Ahmed, I; Arshad, M; Farooq, MA; Fiaz, M; Hassan, SMU; Khokhar, MF; Niazi, AK1
Amelot, M; Bougeard, S; Jouy, E; Keita, A; Kempf, I; Laurentie, J; Mourand, G; Serror, P1

Reviews

1 review(s) available for levofloxacin and oxytetracycline, anhydrous

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for levofloxacin and oxytetracycline, anhydrous

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Adverse effects of levofloxacin and oxytetracycline on aquatic microbial communities.
    The Science of the total environment, 2020, Sep-10, Volume: 734

    Topics: Anti-Bacterial Agents; Levofloxacin; Manure; Microbiota; Oxytetracycline

2020
Antibiotics induced changes in nitrogen metabolism and antioxidative enzymes in mung bean (Vigna radiata).
    The Science of the total environment, 2023, May-15, Volume: 873

    Topics: Anti-Bacterial Agents; Antioxidants; Fabaceae; Glutamate-Ammonia Ligase; Levofloxacin; Oxytetracycline; Soil; Vigna

2023
Study of the effect of administration of narasin or antibiotics on in vivo selection of a narasin- and multidrug-resistant Enterococcus cecorum strain.
    Veterinary microbiology, 2023, Volume: 282

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Levofloxacin; Oxytetracycline; Vancomycin

2023